{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:50:34Z","timestamp":1790139034055,"version":"4.0.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T00:00:00Z","timestamp":1523836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T00:00:00Z","timestamp":1523836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY026174"],"award-info":[{"award-number":["R01EY026174"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30EY014801"],"award-info":[{"award-number":["P30EY014801"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["EPID-006-15S"],"award-info":[{"award-number":["EPID-006-15S"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s40266-018-0545-3","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T06:05:32Z","timestamp":1523858732000},"page":"399-408","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["A Glimpse into Uveitis in the Aging Eye: Pathophysiology, Clinical Presentation and Treatment Considerations"],"prefix":"10.1007","volume":"35","author":[{"given":"Elizabeth","family":"Akinsoji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Goldhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Galor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,16]]},"reference":[{"key":"545_CR1","doi-asserted-by":"publisher","first-page":"509456","DOI":"10.1155\/2015\/509456","volume":"2015","author":"MR Abdulaal","year":"2015","unstructured":"Abdulaal MR, Abiad BH, Hamam RN. Uveitis in the aging eye: incidence, patterns, and differential diagnosis. J Ophthalmol. 2015;2015:509456.","journal-title":"J Ophthalmol"},{"key":"545_CR2","unstructured":"National Eye Institute. Facts about uveitis. 2018. \n                    https:\/\/nei.nih.gov\/health\/uveitis\/uveitis\n                    \n                  ."},{"key":"545_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature Working G. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509\u201316.","journal-title":"Am J Ophthalmol"},{"key":"545_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2165\/00002512-200623070-00001","volume":"23","author":"R Gupta","year":"2006","unstructured":"Gupta R, Murray PI. Chronic non-infectious uveitis in the elderly: epidemiology, pathophysiology and management. Drugs Aging. 2006;23:535\u201358.","journal-title":"Drugs Aging"},{"key":"545_CR5","unstructured":"American Academy of Ophthalmology. Intermediate uveitis in children. 2016. \n                    https:\/\/www.aao.org\/eyenet\/article\/intermediate-uveitis-in-children\n                    \n                  .)"},{"key":"545_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.exger.2006.11.019","volume":"42","author":"DJ Rossi","year":"2007","unstructured":"Rossi DJ, Bryder D, Weissman IL. Hematopoietic stem cell aging: mechanism and consequence. Exp Gerontol. 2007;42:385\u201390.","journal-title":"Exp Gerontol"},{"key":"545_CR7","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1017\/S0029665199000907","volume":"58","author":"B Lesourd","year":"1999","unstructured":"Lesourd B, Mazari L. Nutrition and immunity in the elderly. Proc Nutr Soc. 1999;58:685\u201395.","journal-title":"Proc Nutr Soc"},{"issue":"7","key":"545_CR8","doi-asserted-by":"publisher","first-page":"840","DOI":"10.15252\/embj.201694969","volume":"36","author":"N Guidi","year":"2017","unstructured":"Guidi N, Sacma M, St\u00e4ndker L, Soller K, Marka G, Eiwen K, Weiss JM, Kirchhoff F, Weil T, Cancelas JA, Florian MC, Geiger H. Osteopontin attenuates aging-associated phenotypes of hematopoietic stem cells. EMBO J. 2017;36(7):840\u201353. \n                    https:\/\/doi.org\/10.15252\/embj.201694969\n                    \n                  .","journal-title":"EMBO J."},{"key":"545_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12948-017-0077-0","volume":"15","author":"MT Ventura","year":"2017","unstructured":"Ventura MT, Casciaro M, Gangemi S, Buquicchio R. Immunosenescence in aging: between immune cells depletion and cytokines up-regulation. Clin Mol Allergy. 2017;15:21.","journal-title":"Clin Mol Allergy"},{"issue":"1821","key":"545_CR10","doi-asserted-by":"publisher","first-page":"20143085","DOI":"10.1098\/rspb.2014.3085","volume":"282","author":"AK Simon","year":"2015","unstructured":"Simon AK, Hollander GA, McMichael A. Evolution of the immune system in humans from infancy to old age. Proc Biol Sci. 2015;282(1821):20143085. \n                    https:\/\/doi.org\/10.1098\/rspb.2014.3085\n                    \n                  .","journal-title":"Proc Biol Sci."},{"key":"545_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.micron.2003.11.005","volume":"35","author":"HC Wulf","year":"2004","unstructured":"Wulf HC, Sandby-M\u00f8ller J, Kobayasi T, Gniadecki R. Skin aging and natural photoprotection. Micron. 2004;35:185\u201391.","journal-title":"Micron"},{"key":"545_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1753-4887.1992.tb02482.x","volume":"50","author":"RK Chandra","year":"1992","unstructured":"Chandra RK. Nutrition and immunity in the elderly. Nutr Rev. 1992;50:367\u201371.","journal-title":"Nutr Rev"},{"key":"545_CR13","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1189\/jlb.0603272","volume":"74","author":"TR Malek","year":"2003","unstructured":"Malek TR. The main function of IL-2 is to promote the development of T regulatory cells. J Leukoc Biol. 2003;74:961\u20135.","journal-title":"J Leukoc Biol"},{"key":"545_CR14","unstructured":"The origins of memory T cells. Nature, 2017. 2018, at \n                    https:\/\/www.nature.com\/articles\/d41586-017-08280-8\n                    \n                  ."},{"key":"545_CR15","unstructured":"Effector CD8 T cells dedifferentiate into long-lived memory cells. Nature, 2017. 2018, at \n                    https:\/\/www.nature.com\/articles\/nature25144\n                    \n                  ."},{"key":"545_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/978-1-4419-6451-9_3","volume":"684","author":"O Boyman","year":"2010","unstructured":"Boyman O, Cho JH, Sprent J. The role of interleukin-2 in memory CD8 cell differentiation. Adv Exp Med Biol. 2010;684:28\u201341.","journal-title":"Adv Exp Med Biol"},{"key":"545_CR17","first-page":"595","volume":"138","author":"N Salam","year":"2013","unstructured":"Salam N, Rane S, Das R, et al. T cell ageing: effects of age on development, survival and function. Indian J Med Res. 2013;138:595\u2013608.","journal-title":"Indian J Med Res"},{"key":"545_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nri2496","volume":"9","author":"DL Woodland","year":"2009","unstructured":"Woodland DL, Kohlmeier JE. Migration, maintenance and recall of memory T cells in peripheral tissues. Nat Rev Immunol. 2009;9:153\u201361.","journal-title":"Nat Rev Immunol"},{"key":"545_CR19","doi-asserted-by":"publisher","first-page":"15053","DOI":"10.1073\/pnas.2433717100","volume":"100","author":"L Haynes","year":"2003","unstructured":"Haynes L, Eaton SM, Burns EM, Randall TD, Swain SL. CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly. Proc Natl Acad Sci. 2003;100:15053\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"545_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/microbiolspec.AID-0019-2014","volume":"2","author":"DN Forthal","year":"2014","unstructured":"Forthal DN. Functions of antibodies. Microbiol Spectr. 2014;2:1\u201317.","journal-title":"Microbiol Spectr"},{"key":"545_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.autrev.2004.03.004","volume":"3","author":"E Boren","year":"2004","unstructured":"Boren E, Gershwin ME. Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmun Rev. 2004;3:401\u20136.","journal-title":"Autoimmun Rev"},{"key":"545_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1046\/j.1365-2249.2001.01454.x","volume":"123","author":"R Attanasio","year":"2001","unstructured":"Attanasio R, Brasky KM, Robbins SH, Jayashankar L, Nash RJ, Butler TM. Age-related autoantibody production in a nonhuman primate model. Clin Exp Immunol. 2001;123:361\u20135.","journal-title":"Clin Exp Immunol"},{"key":"545_CR23","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/gerona\/glu057","volume":"69","author":"C Franceschi","year":"2014","unstructured":"Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol Ser A. 2014;69:S4\u20139.","journal-title":"J Gerontol Ser A"},{"key":"545_CR24","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1126\/science.270.5239.1189","volume":"270","author":"TS Griffith","year":"1995","unstructured":"Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 1995;270:1189\u201392.","journal-title":"Science"},{"key":"545_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/09273948.2016.1277247","volume":"26","author":"H Ghasemi","year":"2018","unstructured":"Ghasemi H. Roles of IL-6 in ocular inflammation: a review. Ocul Immunol Inflamm. 2018;26:37\u201350.","journal-title":"Ocul Immunol Inflamm"},{"key":"545_CR26","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.jamda.2013.05.009","volume":"14","author":"M Michaud","year":"2013","unstructured":"Michaud M, Balardy L, Moulis G, et al. Proinflammatory cytokines, aging, and age-related diseases. J Am Med Directors Assoc. 2013;14:877\u201382.","journal-title":"J Am Med Directors Assoc"},{"key":"545_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.exger.2017.10.014","volume":"105","author":"T Mau","year":"2018","unstructured":"Mau T, Yung R. Adipose tissue inflammation in aging. Exp Gerontol. 2018;105:27\u201331.","journal-title":"Exp Gerontol"},{"key":"545_CR28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/ar2952","volume":"12","author":"N Busso","year":"2010","unstructured":"Busso N, So A. Gout. Mechanisms of inflammation in gout. Arthritis Res Ther. 2010;12:206.","journal-title":"Arthritis Res Ther"},{"key":"545_CR29","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S0047-6374(02)00035-0","volume":"123","author":"S Stacy","year":"2002","unstructured":"Stacy S, Krolick KA, Infante AJ, Kraig E. Immunological memory and late onset autoimmunity. Mech Ageing Dev. 2002;123:975\u201385.","journal-title":"Mech Ageing Dev"},{"key":"545_CR30","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/BF00157064","volume":"70","author":"HA Hylkema","year":"1988","unstructured":"Hylkema HA. The role of the immune system in uveitis induced in animals. Doc Ophthalmol Adv Ophthalmol. 1988;70:339\u201351.","journal-title":"Doc Ophthalmol Adv Ophthalmol"},{"key":"545_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-3-319-17121-0_9","volume":"854","author":"CJ Ildefonso","year":"2016","unstructured":"Ildefonso CJ, Biswal MR, Ahmed CM, Lewin AS. The NLRP3 inflammasome and its role in age-related macular degeneration. Adv Exp Med Biol. 2016;854:59\u201365.","journal-title":"Adv Exp Med Biol"},{"issue":"307","key":"545_CR32","first-page":"e1","volume":"113","author":"SW Reeves","year":"2006","unstructured":"Reeves SW, Sloan FA, Lee PP, Jaffe GJ. Uveitis in the elderly: epidemiological data from the National Long-term Care Survey Medicare Cohort. Ophthalmology. 2006;113(307):e1.","journal-title":"Ophthalmology"},{"key":"545_CR33","doi-asserted-by":"publisher","first-page":"e85224","DOI":"10.1371\/journal.pone.0085224","volume":"9","author":"L Hoeksema","year":"2014","unstructured":"Hoeksema L, Los LI. Vision-related quality of life in herpetic anterior uveitis patients. PloS One. 2014;9:e85224.","journal-title":"PloS One"},{"key":"545_CR34","unstructured":"Foster CS, Vitale AT. Diagnosis and treatment of uveitis. Jaypee Highlights Medical Publishers, Inc. 2013."},{"key":"545_CR35","unstructured":"American Academy of Ophthalmology (Eye Wiki). Herpes simplex virus keratitis. 2017. \n                    http:\/\/eyewiki.aao.org\/Herpes_simplex_uveitis\n                    \n                  ."},{"key":"545_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5301\/ejo.5000331","volume":"24","author":"P Nalcacioglu-Y\u00fcksekkaya","year":"2013","unstructured":"Nalcacioglu-Y\u00fcksekkaya P, Ozdal PC, Teke MY, Kara C, Ozturk F. Presumed herpetic anterior uveitis: a study with retrospective analysis of 79 cases. Eur J Ophthalmol. 2013;24:14\u201320.","journal-title":"Eur J Ophthalmol"},{"key":"545_CR37","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.ajo.2012.12.008","volume":"155","author":"Z Anwar","year":"2013","unstructured":"Anwar Z, Galor A, Albini TA, Miller D, Perez V, Davis JL. The diagnostic utility of anterior chamber paracentesis with polymerase chain reaction in anterior uveitis. Am J Ophthalmol. 2013;155:781\u20136.","journal-title":"Am J Ophthalmol"},{"key":"545_CR38","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1001\/archopht.1996.01100140267002","volume":"114","author":"The Herpetic Eye Disease Study Group","year":"1996","unstructured":"The Herpetic Eye Disease Study Group. A controlled trial of oral acyclovir for iridocyclitis caused by herpes simplex virus. Arch Ophthalmol. 1996;114:1065\u201372.","journal-title":"Arch Ophthalmol"},{"key":"545_CR39","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/08820530500232027","volume":"20","author":"AA Bonfioli","year":"2005","unstructured":"Bonfioli AA, Eller AW. Acute retinal necrosis. Semin Ophthalmol. 2005;20:155\u201360.","journal-title":"Semin Ophthalmol"},{"key":"545_CR40","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00131023","volume":"11","author":"GC Brown","year":"1988","unstructured":"Brown GC, Magargal LE. The ocular ischemic syndrome. Clinical, fluorescein angiographic and carotid angiographic features. Int Ophthalmol. 1988;11:239\u201351.","journal-title":"Int Ophthalmol"},{"key":"545_CR41","first-page":"138","volume":"18","author":"B Terelak-Borys","year":"2012","unstructured":"Terelak-Borys B, Skonieczna K, Grabska-Liberek I. Ocular ischemic syndrome\u2014a systematic review. Med Sci Monit Int Med J Exp Clin Res. 2012;18:138\u201344.","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"key":"545_CR42","first-page":"113","volume":"2","author":"LE Magargal","year":"1982","unstructured":"Magargal LE, Sanborn GE, Zimmerman A. Venous stasis retinopathy associated with embolic obstruction of the central retinal artery. J Clin Neuro Ophthalmol. 1982;2:113\u20138.","journal-title":"J Clin Neuro Ophthalmol"},{"key":"545_CR43","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.ccm.2015.08.009","volume":"36","author":"S Pasadhika","year":"2015","unstructured":"Pasadhika S, Rosenbaum JT. Ocular sarcoidosis. Clin Chest Med. 2015;36:669\u201383.","journal-title":"Clin Chest Med"},{"key":"545_CR44","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ophtha.2017.07.006","volume":"125","author":"NR Acharya","year":"2018","unstructured":"Acharya NR, Browne EN, Rao N, Mochizuki M. Distinguishing features of ocular sarcoidosis in an international cohort of uveitis patients. Ophthalmology. 2018;125:119\u201326.","journal-title":"Ophthalmology"},{"key":"545_CR45","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/ICU.0000000000000415","volume":"28","author":"H Kefella","year":"2017","unstructured":"Kefella H, Luther D, Hainline C. Ophthalmic and neuro-ophthalmic manifestations of sarcoidosis. Curr Opin Ophthalmol. 2017;28:587\u201394.","journal-title":"Curr Opin Ophthalmol"},{"key":"545_CR46","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1086\/378097","volume":"73","author":"MD Rossman","year":"2003","unstructured":"Rossman MD, Thompson B, Frederick M, et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet. 2003;73:720\u201335.","journal-title":"Am J Hum Genet"},{"key":"545_CR47","unstructured":"Pathology and pathogenesis of sarcoidosis. 2017. \n                    https:\/\/www.uptodate.com\/contents\/pathology-and-pathogenesis-of-sarcoidosis\n                    \n                  ."},{"key":"545_CR48","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1136\/bjo.45.7.461","volume":"45","author":"RP Crick","year":"1961","unstructured":"Crick RP, Hoyle C, Smellie H. The eyes in sarcoidosis. Br J Ophthalmol. 1961;45:461\u201381.","journal-title":"Br J Ophthalmol"},{"key":"545_CR49","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1001\/archopht.1961.01840020455023","volume":"65","author":"H Gould","year":"1961","unstructured":"Gould H, Kaufman HE. Sarcoid of the fundus. Arch Ophthalmol (Chicago, Ill: 1960). 1961;65:453\u20136.","journal-title":"Arch Ophthalmol (Chicago, Ill: 1960)"},{"key":"545_CR50","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/eye.2015.65","volume":"29","author":"H Mehta","year":"2015","unstructured":"Mehta H, Sim DA, Keane PA, et al. Structural changes of the choroid in sarcoid- and tuberculosis-related granulomatous uveitis. Eye (Lond, Engl). 2015;29:1060\u20138.","journal-title":"Eye (Lond, Engl)"},{"key":"545_CR51","first-page":"26","volume":"29","author":"RP Baughman","year":"2012","unstructured":"Baughman RP, Lower EE, Ingledue R, Kaufman AH. Management of ocular sarcoidosis. Sarcoidosis Vasc Diffus Lung Dis Off J WASOG. 2012;29:26\u201333.","journal-title":"Sarcoidosis Vasc Diffus Lung Dis Off J WASOG"},{"key":"545_CR52","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1634\/theoncologist.2011-0210","volume":"16","author":"CC Chan","year":"2011","unstructured":"Chan CC, Rubenstein JL, Coupland SE, et al. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium. Oncol. 2011;16:1589\u201399.","journal-title":"Oncol"},{"key":"545_CR53","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00417-004-0973-0","volume":"242","author":"SE Coupland","year":"2004","unstructured":"Coupland SE, Heimann H, Bechrakis NE. Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features. Graefe\u2019s Arch Clin Exp Ophthalmol. 2004;242:901\u201313.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"545_CR54","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1038\/bjc.2011.357","volume":"105","author":"JL Villano","year":"2011","unstructured":"Villano JL, Koshy M, Shaikh H, Dolecek TA, McCarthy BJ. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma. Br J Cancer. 2011;105:1414\u20138.","journal-title":"Br J Cancer"},{"key":"545_CR55","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/jnci\/djj248","volume":"98","author":"R Moslehi","year":"2006","unstructured":"Moslehi R, Devesa SS, Schairer C, Fraumeni JF Jr. Rapidly increasing incidence of ocular non-Hodgkin lymphoma. J Natl Cancer Inst. 2006;98:936\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"545_CR56","unstructured":"Clinical presentation, pathologic features, and diagnosis of primary central nervous system lymphoma. 2017. 2017, at \n                    https:\/\/www.uptodate.com\/contents\/clinical-presentation-pathologic-features-and-diagnosis-of-primary-central-nervous-system-lymphoma?source=search_result&search=ocularlymphoma&selectedTitle=1~150#H8\n                    \n                  ."},{"key":"545_CR57","first-page":"247","volume":"1","author":"K Jahnke","year":"2007","unstructured":"Jahnke K, Thiel E, Abrey LE, Neuwelt EA, Korfel A. Diagnosis and management of primary intraocular lymphoma: an update. Clin Ophthalmol (Auckland, NZ). 2007;1:247\u201358.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"key":"545_CR58","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/S0161-6420(99)90341-X","volume":"106","author":"EK Akpek","year":"1999","unstructured":"Akpek EK, Ahmed I, Hochberg FH, et al. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology. 1999;106:1805\u201310.","journal-title":"Ophthalmology"},{"key":"545_CR59","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3109\/10428194.2013.819576","volume":"55","author":"S Teckie","year":"2014","unstructured":"Teckie S, Yahalom J. Primary intraocular lymphoma: treatment outcomes with ocular radiation therapy alone. Leuk Lymphoma. 2014;55:795\u2013801.","journal-title":"Leuk Lymphoma"},{"key":"545_CR60","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00277-015-2582-x","volume":"95","author":"WL Ma","year":"2016","unstructured":"Ma WL, Hou HA, Hsu YJ, et al. Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection. Ann Hematol. 2016;95:593\u2013601.","journal-title":"Ann Hematol"},{"key":"545_CR61","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/1755738015614038","volume":"9","author":"DA Cantlay","year":"2016","unstructured":"Cantlay DA, Glyn DT, Barton DN. Polypharmacy in the elderly. InnovAiT. 2016;9:69\u201377.","journal-title":"InnovAiT"},{"key":"545_CR62","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2165\/00002512-200522030-00005","volume":"22","author":"EJ MacLaughlin","year":"2005","unstructured":"MacLaughlin EJ, Raehl CL, Treadway AK, Sterling TL, Zoller DP, Bond CA. Assessing medication adherence in the elderly. Drugs Aging. 2005;22:231\u201355.","journal-title":"Drugs Aging"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-018-0545-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-018-0545-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-018-0545-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T22:25:07Z","timestamp":1589667907000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-018-0545-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,16]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["545"],"URL":"https:\/\/doi.org\/10.1007\/s40266-018-0545-3","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,16]]},"assertion":[{"value":"16 April 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No conflicting relationship exists for any author.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences Research EPID-006-15S (Dr. Galor), R01EY026174 (Dr. Galor), NIH Center Core Grant P30EY014801 and Research to Prevent Blindness Unrestricted Grant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial support"}}]}}